Ledger.Open graph →
SEC Form D · filed October 7, 2019

EpiVax Oncology, Inc

Offering
$1.3M
Sold
$375K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
New York, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Anne De Groot · Providence, RIExec · DirectorWilliam Martin · Providence, RIExecClifford Grimm · Providence, RIExecDaniel Adams · Providence, RIDirectorGad Berdugo · New York, NYExec · DirectorChilton Investment Services, LLC · Stamford, CTExec · DirectorStephen P. Schuler · Chicago, ILExecRichard L. Chilton · Stamford, CTExecAndrew Clark · Duxbury, MAExec · DirectorSusan E. Lattman · Basking Ridge, NJExecAlun Williams · NEW YORK, NYExecDaniel Adams · American Fork, UTDirectorGad Berdugo · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗